Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21


Plasma kallikrein mediates retinal vascular dysfunction and induces retinal thickening in diabetic rats.

Clermont A, Chilcote TJ, Kita T, Liu J, Riva P, Sinha S, Feener EP.

Diabetes. 2011 May;60(5):1590-8. doi: 10.2337/db10-1260. Epub 2011 Mar 28.


Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein.

Liu J, Gao BB, Clermont AC, Blair P, Chilcote TJ, Sinha S, Flaumenhaft R, Feener EP.

Nat Med. 2011 Feb;17(2):206-10. doi: 10.1038/nm.2295. Epub 2011 Jan 23.


Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability.

Phipps JA, Clermont AC, Sinha S, Chilcote TJ, Bursell SE, Feener EP.

Hypertension. 2009 Feb;53(2):175-81. doi: 10.1161/HYPERTENSIONAHA.108.117663. Epub 2009 Jan 5.


Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system.

Inglis KJ, Chereau D, Brigham EF, Chiou SS, Schöbel S, Frigon NL, Yu M, Caccavello RJ, Nelson S, Motter R, Wright S, Chian D, Santiago P, Soriano F, Ramos C, Powell K, Goldstein JM, Babcock M, Yednock T, Bard F, Basi GS, Sham H, Chilcote TJ, McConlogue L, Griswold-Prenner I, Anderson JP.

J Biol Chem. 2009 Jan 30;284(5):2598-602. doi: 10.1074/jbc.C800206200. Epub 2008 Nov 12.


Red blood cells are the major source of alpha-synuclein in blood.

Barbour R, Kling K, Anderson JP, Banducci K, Cole T, Diep L, Fox M, Goldstein JM, Soriano F, Seubert P, Chilcote TJ.

Neurodegener Dis. 2008;5(2):55-9. doi: 10.1159/000112832. Epub 2008 Jan 4.


Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.

Anderson JP, Walker DE, Goldstein JM, de Laat R, Banducci K, Caccavello RJ, Barbour R, Huang J, Kling K, Lee M, Diep L, Keim PS, Shen X, Chataway T, Schlossmacher MG, Seubert P, Schenk D, Sinha S, Gai WP, Chilcote TJ.

J Biol Chem. 2006 Oct 6;281(40):29739-52. Epub 2006 Jul 17.


Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease.

Masliah E, Rockenstein E, Adame A, Alford M, Crews L, Hashimoto M, Seubert P, Lee M, Goldstein J, Chilcote T, Games D, Schenk D.

Neuron. 2005 Jun 16;46(6):857-68.


Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death.

Wogulis M, Wright S, Cunningham D, Chilcote T, Powell K, Rydel RE.

J Neurosci. 2005 Feb 2;25(5):1071-80.


Lack of correlation between caspase activation and caspase activity assays in paclitaxel-treated MCF-7 breast cancer cells.

Kottke TJ, Blajeski AL, Meng XW, Svingen PA, Ruchaud S, Mesner PW Jr, Boerner SA, Samejima K, Henriquez NV, Chilcote TJ, Lord J, Salmon M, Earnshaw WC, Kaufmann SH.

J Biol Chem. 2002 Jan 4;277(1):804-15. Epub 2001 Oct 24.


Characterization of caspase processing and activation in HL-60 cell cytosol under cell-free conditions. Nucleotide requirement and inhibitor profile.

Mesner PW Jr, Bible KC, Martins LM, Kottke TJ, Srinivasula SM, Svingen PA, Chilcote TJ, Basi GS, Tung JS, Krajewski S, Reed JC, Alnemri ES, Earnshaw WC, Kaufmann SH.

J Biol Chem. 1999 Aug 6;274(32):22635-45.


Localization of cellubrevin to the Golgi complex in pancreatic acinar cells.

Sengupta D, Gumkowski FD, Tang LH, Chilcote TJ, Jamieson JD.

Eur J Cell Biol. 1996 Aug;70(4):306-14.


v- and t-SNAREs in neuronal exocytosis: a need for additional components to define sites of release.

Galli T, Garcia EP, Mundigl O, Chilcote TJ, De Camilli P.

Neuropharmacology. 1995 Nov;34(11):1351-60. Review.


Cellubrevin and synaptobrevins: similar subcellular localization and biochemical properties in PC12 cells.

Chilcote TJ, Galli T, Mundigl O, Edelmann L, McPherson PS, Takei K, De Camilli P.

J Cell Biol. 1995 Apr;129(1):219-31.


rbSec1A and B colocalize with syntaxin 1 and SNAP-25 throughout the axon, but are not in a stable complex with syntaxin.

Garcia EP, McPherson PS, Chilcote TJ, Takei K, De Camilli P.

J Cell Biol. 1995 Apr;129(1):105-20.


Synapsin IIa bundles actin filaments.

Chilcote TJ, Siow YL, Schaeffer E, Greengard P, Thiel G.

J Neurochem. 1994 Oct;63(4):1568-71.


Interaction of Grb2 via its Src homology 3 domains with synaptic proteins including synapsin I.

McPherson PS, Czernik AJ, Chilcote TJ, Onofri F, Benfenati F, Greengard P, Schlessinger J, De Camilli P.

Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6486-90.


Tetanus toxin-mediated cleavage of cellubrevin impairs exocytosis of transferrin receptor-containing vesicles in CHO cells.

Galli T, Chilcote T, Mundigl O, Binz T, Niemann H, De Camilli P.

J Cell Biol. 1994 Jun;125(5):1015-24.


Synapsin IIa: expression in insect cells, purification, and characterization.

Siow YL, Chilcote TJ, Benfenati F, Greengard P, Thiel G.

Biochemistry. 1992 May 5;31(17):4268-75.


Synapsin I regulates glutamate release from rat brain synaptosomes.

Nichols RA, Chilcote TJ, Czernik AJ, Greengard P.

J Neurochem. 1992 Feb;58(2):783-5.


Phosphorylation of Tetrahymena 22 S dynein.

Chilcote TJ, Johnson KA.

J Biol Chem. 1990 Oct 5;265(28):17257-66.


Dynein structure and function.

Johnson KA, Marchese-Ragona SP, Clutter DB, Holzbaur EL, Chilcote TJ.

J Cell Sci Suppl. 1986;5:189-96. Review.


Supplemental Content

Loading ...
Support Center